None listed
Conditions
Interventions
None listed
Sponsors
Seoul National University Bundang Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Among all adult (>=18years) patients with Staphylococcus aureus bacteremia at participating hospital during the study period 1) Patients who agree to the gathering clinical information about S. aureus bacteremia by means of an informed consent. 2) Patients who fulfill the criteria of a waiver: Patients who died or transferred within 2 weeks after the onset of bacteremia, an informed consent was waived by institutional review board. Vancomycin-treated patient with methicillin-resistant Staphylococcus aureus bacteremia who fulfill the above criteria.
Exclusion criteria
Exclusion criteria: Patienst who do not agree the participation in this study, except for patients who fulfill the criteria of a waiver of informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment failure: (1) death within 30 days, or (2) persisent MSSA bacteremia for more than 7 days, or (3) recurrence of MSSA bacteremia within 30 days after completion of antibiotic treatment) ;MRSA bacteremia-associated mortality | — |
Secondary
| Measure | Time frame |
|---|---|
| Analysis of risk factors for treatment failure ;Replacement of antibiotics due to adverse effect of vancomycin;Analysis of relationship between vancomycin MIC and treatment outcome;Analysis of relationship between archievement of target trough level and treatment outcome | — |
Countries
Korea, Republic of
Contacts
Public ContactKyoung-Ho Song
Seoul National University Bundang Hospital
Outcome results
None listed